pharmaphorum

APRIL 16, 2021

Taking the longer term view of the last seven years, 2020 was a rather good year for innovative medicine approvals in both the US and Europe – an improvement on 2019, even with the extra approvals of COVID treatments and the first of the vaccines accounted for. Here we assess the launches of New Active Substances (NAS) only.

Sales 95

Sales Marketing Medicine Doctors 95

Pharma Marketing Network

JUNE 8, 2020

This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. I started my career in consulting implementing systems inside of a couple dozen different hospitals and then I went on to find Microsoft’s healthcare partner ecosystem. Don (PMN): Hi welcome.

HR 40

HR Marketing Doctors Doctor 40

XTalks

SEPTEMBER 14, 2020

“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Countries that are now queuing up to ensure they get a vaccine first threaten to undermine that goal.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92